Appetite suppression intensity: Retatrutide produces profound appetite reduction that some find challenging
Results Thirty one studies 13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43 were selected after following inclusion and exclusion criteria
Because retatrutide has no approved form, compounding pharmacies cannot legally produce it under the exemptions that apply to approved medications like semaglutide or tirzepatide
GLP-1s should be avoided in anyone with a personal or family history of MTC or MEN2 (Multiple Endocrine Neoplasia Type 2)
The mechanism of action involves several complementary pathways: Enhanced insulin secretion : GLP-1 agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin is only released when blood glucose levels are elevated, thereby reducing the risk of hypoglycaemia
It is often described as a triple-agonist